SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at the Goldman Sachs 33rd Annual Global Healthcare Conference at 12:20 p.m. EDT / 9:20 a.m. PDT on Wednesday, June 6, 2012, in Rancho Palos Verdes, California. During the presentation, Dr. Morrissey will discuss the company’s development program and plans for cabozantinib, and review the most recent publicly available data for the compound, including data presented at the 2012 ASCO Annual Meeting. He will also provide a general business update.
